Answer
The Neurodegenerative Disease Laboratory at EPFL, led by Patrick Aebischer, primarily focuses on researching and developing treatments for neurodegenerative diseases such as Parkinson's and Alzheimer's. These diseases affect millions of people worldwide and are characterized by the progressive loss of nerve cells in the brain.